IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.86M | 3.18M | 3.58M | 3.17M | 3.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.86M | 3.18M | 3.58M | 3.17M | 3.13M |
| Operating Income | -2.86M | -3.18M | -3.58M | -3.17M | -3.13M |
| Income Before Tax | -5.28M | -4.21M | -4.44M | -7.65M | -6.46M |
| Income Tax Expenses | -4.20K | -4.20K | -- | -- | -- |
| Earnings from Continuing Operations | -5.28 | -4.20 | -4.44 | -7.65 | -6.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.28M | -4.20M | -4.44M | -7.65M | -6.46M |
| EBIT | -2.86M | -3.18M | -3.58M | -3.17M | -3.13M |
| EBITDA | -2.85M | -3.17M | -3.57M | -3.16M | -3.11M |
| EPS Basic | -0.36 | -0.29 | -0.34 | -0.57 | -0.49 |
| Normalized Basic EPS | -0.19 | -0.22 | -0.26 | -0.25 | -0.26 |
| EPS Diluted | -0.36 | -0.29 | -0.34 | -0.57 | -0.49 |
| Normalized Diluted EPS | -0.19 | -0.22 | -0.26 | -0.25 | -0.26 |
| Average Basic Shares Outstanding | 63.13M | 59.42M | 55.79M | 53.58M | 52.73M |
| Average Diluted Shares Outstanding | 63.13M | 59.42M | 55.79M | 53.58M | 52.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |